FR139317, a specific ETA-receptor antagonist, inhibits cerebral activation by intraventricular endothelin-1 in conscious rats
- 31 October 1994
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 33 (10) , 1155-1166
- https://doi.org/10.1016/s0028-3908(05)80005-x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- NMDA-mediated metabolic activation of the cerebellar cortex in behaving rats by the neuropeptide endothelin-1Brain Research, 1994
- Endothelin Levels Increase in Rat Focal and Global IschemiaJournal of Cerebral Blood Flow & Metabolism, 1994
- A specific endothelin subtype A receptor antagonist protects against injury in renal disease progressionKidney International, 1993
- Characterization of endothelin-A receptors in the cerebral circulationNeuroReport, 1993
- A novel ETA‐receptor antagonist, FR 139317, inhibits endothelin‐induced contractions of guinea‐pig pulmonary arteries, but not tracheaBritish Journal of Pharmacology, 1993
- Inositol trisphosphate and calcium signallingNature, 1993
- Regional and subcellular distribution of [125i]endothelin binding sites in rat brainBrain Research Bulletin, 1992
- Production of seizures and brain damage in rats by α-dendrotoxin, a selective K+ channel blockerNeuroscience Letters, 1992
- Domoic Acid Toxicity in Rats and Mice after Intracerebroventricular Administration: Comparison with Excitatory Amino Acid AgonistsBasic & Clinical Pharmacology & Toxicology, 1992
- Glutamate, nitric oxide and cell-cell signalling in the nervous systemTrends in Neurosciences, 1991